Publication | Closed Access

A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: In vitro and in vivo study

Novel Synthetic CompoundMedicinal ChemistryReactive Oxygen SpeciesMedicineAnti-cancer AgentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug DiscoveryCisplatin-induced Hearing Loss